» Articles » PMID: 22596259

Osteoblastic N-cadherin is Not Required for Microenvironmental Support and Regulation of Hematopoietic Stem and Progenitor Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 May 19
PMID 22596259
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cell (HSC) regulation is highly dependent on interactions with the marrow microenvironment. Controversy exists on N-cadherin's role in support of HSCs. Specifically, it is unknown whether microenvironmental N-cadherin is required for normal marrow microarchitecture and for hematopoiesis. To determine whether osteoblastic N-cadherin is required for HSC regulation, we used a genetic murine model in which deletion of Cdh2, the gene encoding N-cadherin, has been targeted to cells of the osteoblastic lineage. Targeted deletion of N-cadherin resulted in an age-dependent bone phenotype, ultimately characterized by decreased mineralized bone, but no difference in steady-state HSC numbers or function at any time tested, and normal recovery from myeloablative injury. Intermittent parathyroid hormone (PTH) treatment is well established as anabolic to bone and to increase marrow HSCs through microenvironmental interactions. Lack of osteoblastic N-cadherin did not block the bone anabolic or the HSC effects of PTH treatment. This report demonstrates that osteoblastic N-cadherin is not required for regulation of steady-state hematopoiesis, HSC response to myeloablation, or for rapid expansion of HSCs through intermittent treatment with PTH.

Citing Articles

Hematopoietic stem cell metabolism within the bone marrow niche - insights and opportunities.

Kemna K, van der Burg M, Lankester A, Giera M Bioessays. 2024; 47(2):e2400154.

PMID: 39506498 PMC: 11755706. DOI: 10.1002/bies.202400154.


Systemic and local regulation of hematopoietic homeostasis in health and disease.

Carpenter R, Maryanovich M Nat Cardiovasc Res. 2024; 3(6):651-665.

PMID: 39196230 DOI: 10.1038/s44161-024-00482-4.


Osteoblast Lineage Support of Hematopoiesis in Health and Disease.

Kim M, Valderrabano R, Wu J J Bone Miner Res. 2022; 37(10):1823-1842.

PMID: 35983701 PMC: 11346465. DOI: 10.1002/jbmr.4678.


Peeling Back the Layers of Lymph Gland Structure and Regulation.

Kharrat B, Csordas G, Honti V Int J Mol Sci. 2022; 23(14).

PMID: 35887113 PMC: 9319083. DOI: 10.3390/ijms23147767.


Recent advances in "sickle and niche" research - Tribute to Dr. Paul S Frenette.

Torres L, Asada N, Weiss M, Trumpp A, Suda T, Scadden D Stem Cell Reports. 2022; 17(7):1509-1535.

PMID: 35830837 PMC: 9287685. DOI: 10.1016/j.stemcr.2022.06.004.


References
1.
Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

2.
Kiel M, Acar M, Radice G, Morrison S . Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell. 2009; 4(2):170-9. PMC: 2681089. DOI: 10.1016/j.stem.2008.10.005. View

3.
Goltzman D . Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch Biochem Biophys. 2008; 473(2):218-24. DOI: 10.1016/j.abb.2008.03.003. View

4.
Frisch B, Ashton J, Xing L, Becker M, Jordan C, Calvi L . Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood. 2011; 119(2):540-50. PMC: 3384480. DOI: 10.1182/blood-2011-04-348151. View

5.
Frisch B, Porter R, Gigliotti B, Olm-Shipman A, Weber J, OKeefe R . In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood. 2009; 114(19):4054-63. PMC: 2774547. DOI: 10.1182/blood-2009-03-205823. View